Back to medical news
MedPage Today
Can DMARD Doses Be Safely Reduced for RA Patients? Korean Trial Says Yes.
October 8, 2026
Original source summary
(MedPage Today) -- Close to 90% of patients with rheumatoid arthritis (RA) well controlled on targeted therapies were able to take 50% dosage reductions without experiencing worsened disease activity in a randomized trial, South Korean researchers...
Verbatim from MedPage Today's own feed — "Can DMARD Doses Be Safely Reduced for RA Patients? Korean Trial Says Yes."
Want more like this?
Browse more from the feed. A free account unlocks the full feed, saving and communities.
More medical news